EU Panel Backs Drugs for Hypoglycemia, Osteoporosis EU Panel Backs Drugs for Hypoglycemia, Osteoporosis

After an initial no, CHMP backs romosozumab for severe osteoporosis with high fracture risk; Baqsimi is the first nasally administered treatment for severe hypoglycemia.International Approvals
Source: Medscape Med Students Headlines - Category: Universities & Medical Training Tags: Diabetes & Endocrinology News Alert Source Type: news